Acquired Amegakaryocytic Thrombocytopenia Overview
Learn About Acquired Amegakaryocytic Thrombocytopenia
Manuela Germeshausen practices in Hannover, Germany. Germeshausen and is rated as an Elite expert by MediFind in the treatment of Acquired Amegakaryocytic Thrombocytopenia. Her top areas of expertise are Acquired Amegakaryocytic Thrombocytopenia, Agranulocytosis, Severe Congenital Neutropenia, and Cyclic Neutropenia.
Matthias Ballmaier practices in Hannover, Germany. Ballmaier and is rated as an Elite expert by MediFind in the treatment of Acquired Amegakaryocytic Thrombocytopenia. His top areas of expertise are Acquired Amegakaryocytic Thrombocytopenia, Bernard-Soulier Syndrome, Thrombocytopenia, and Aplastic Anemia.
Paul Galardy is a Pediatric Hematologist Oncology specialist and a Pediatrics provider in Rochester, Minnesota. Dr. Galardy and is rated as an Elite provider by MediFind in the treatment of Acquired Amegakaryocytic Thrombocytopenia. His top areas of expertise are Acquired Amegakaryocytic Thrombocytopenia, Burkitt Lymphoma, B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Transplant. Dr. Galardy is currently accepting new patients.
Summary: A phase II trial of a reduced intensity conditioned (RIC) allogeneic hematopoietic cell transplant (HCT) with post-transplant cyclophosphamide (PTCy) for idiopathic severe aplastic anemia (SAA), paroxysmal nocturnal hemoglobinuria (PNH), acquired pure red cell aplasia (aPRCA), or acquired amegakaryocytic thrombocytopenia (aAT) utilizing population pharmacokinetic (popPK)-guided individual dosing o...
Summary: Children, adolescents, and young adults with malignant and non-malignant conditionsundergoing an allogeneic stem cell transplantation (AlloSCT) will have the stem cells selected utilizing α/β CD3+/CD19+ cell depletion. All other treatment is standard of care.
Published Date: May 10, 2022
Published By: Genetic and Rare Diseases Informnation Center